His current research is related to pre-slaughter physical conditions, value - added
products, pre - and post-harvest food safety interventions,
effects of physiologic parameters on muscle - to - meat transformation, beef nutritional values and control
of salmonella and E. coli during processing.
Since Deracoxib is a COX - 2 inhibitor, you can expect its
effects to be a negation
of the
physiologic processes attributed to the 3
products of arachidonic acid conversion.